Clinical Trial: Clinical Outcomes in Cataract Surgery With OMNI Canaloplasty vs Cataract Surgery With OMNI Canaloplasty and Hydrus Stent

Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL




Official Title: Comparison of Clinical Outcomes in Patients Undergoing Cataract Surgery With OMNI Canaloplasty vs Cataract Surgery With OMNI Canaloplasty and Hydrus Stent

Brief Summary:

The goal of this clinical trial is to look at the difference in pressure lowering effects in patients having two different combinations of minimally invasive glaucoma surgery (MIGS) at the time of their cataract surgery.
Eligible patients will have mild to moderate glaucoma and be candidates for cataract surgery.
The trial will look at the eye pressure before and one year after cataract surgery in patients.
One eye in each patient will have cataract surgery with canaloplasty using OMNI.
The patients other eye will have cataract surgery with canaloplasty and a HYDRUS stent.
The trial will look at the differences in eye pressure and if patients are able to need fewer eye pressure lowering drops after surgery.

Study participants will undergo preop testing of pressure, vision, slit lamp exam, ocular coherence tomography (OCT) of the nerve fiber layer (NFL) analysis, and visual field prior to cataract surgery with MIGS.
One day, one week, one month, 6 month, and 1 year exams will be performed to check pressure, vision, slit lamp exam, and number of necessary eye pressure medications in each eye.